Decision Diagnostics Stock Performance
| DECN Stock | USD 0.0001 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and Decision Diagnostics are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Decision Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, Decision Diagnostics is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors. ...more
Last Split Factor 1.1:1 | Last Split Date 2011-12-28 |
1 | Plus Therapeutics CNSide Trial Shows 90 percent Success in Cancer Treatment Decisions PSTV Stock News - StockTitan | 11/22/2024 |
| Begin Period Cash Flow | -185.7 K | |
| Total Cashflows From Investing Activities | 50.3 K |
Decision |
Decision Diagnostics Relative Risk vs. Return Landscape
If you would invest 0.01 in Decision Diagnostics on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Decision Diagnostics or generate 0.0% return on investment over 90 days. Decision Diagnostics is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Decision, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Decision Diagnostics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Decision Diagnostics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Decision Diagnostics, and traders can use it to determine the average amount a Decision Diagnostics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| DECN |
Based on monthly moving average Decision Diagnostics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Decision Diagnostics by adding Decision Diagnostics to a well-diversified portfolio.
Decision Diagnostics Fundamentals Growth
Decision Stock prices reflect investors' perceptions of the future prospects and financial health of Decision Diagnostics, and Decision Diagnostics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Decision Stock performance.
| Return On Equity | -81.61 | ||||
| Return On Asset | -0.21 | ||||
| Operating Margin | (0.95) % | ||||
| Current Valuation | 3.06 M | ||||
| Shares Outstanding | 357.87 M | ||||
| Price To Earning | (0.33) X | ||||
| Price To Book | 2.72 X | ||||
| Price To Sales | 0.02 X | ||||
| Revenue | 1.98 M | ||||
| Gross Profit | 194.17 K | ||||
| EBITDA | (2.41 M) | ||||
| Net Income | (29.67 M) | ||||
| Cash And Equivalents | 210.85 K | ||||
| Total Debt | 2.93 M | ||||
| Debt To Equity | 9.05 % | ||||
| Current Ratio | 0.25 X | ||||
| Cash Flow From Operations | (1.4 M) | ||||
| Earnings Per Share | (0.02) X | ||||
| Market Capitalization | 35.79 K | ||||
| Total Asset | 5.65 M | ||||
| Retained Earnings | (79.4 M) | ||||
| Working Capital | (3.3 M) | ||||
| Current Asset | 4.3 M | ||||
| Current Liabilities | 3.06 M | ||||
About Decision Diagnostics Performance
By examining Decision Diagnostics' fundamental ratios, stakeholders can obtain critical insights into Decision Diagnostics' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Decision Diagnostics is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 35.65 | 48.08 | |
| Return On Tangible Assets | (8.44) | (8.02) | |
| Return On Capital Employed | (2.61) | (2.48) | |
| Return On Assets | (4.72) | (4.49) | |
| Return On Equity | (70.55) | (67.03) |
Things to note about Decision Diagnostics performance evaluation
Checking the ongoing alerts about Decision Diagnostics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Decision Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Decision Diagnostics generated a negative expected return over the last 90 days | |
| Decision Diagnostics has some characteristics of a very speculative penny stock | |
| Decision Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| Decision Diagnostics currently holds 2.93 M in liabilities with Debt to Equity (D/E) ratio of 9.05, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Decision Diagnostics has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Decision Diagnostics' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 1.98 M. Net Loss for the year was (29.67 M) with profit before overhead, payroll, taxes, and interest of 194.17 K. | |
| Decision Diagnostics currently holds about 210.85 K in cash with (1.4 M) of positive cash flow from operations. | |
| Decision Diagnostics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Plus Therapeutics CNSide Trial Shows 90 percent Success in Cancer Treatment Decisions PSTV Stock News - StockTitan |
- Analyzing Decision Diagnostics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Decision Diagnostics' stock is overvalued or undervalued compared to its peers.
- Examining Decision Diagnostics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Decision Diagnostics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Decision Diagnostics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Decision Diagnostics' stock. These opinions can provide insight into Decision Diagnostics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Decision Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Decision Diagnostics. If investors know Decision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Decision Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.02) | Revenue Per Share 0.006 | Quarterly Revenue Growth (0) | Return On Assets (0.21) | Return On Equity (81.61) |
The market value of Decision Diagnostics is measured differently than its book value, which is the value of Decision that is recorded on the company's balance sheet. Investors also form their own opinion of Decision Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Decision Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Decision Diagnostics' market value can be influenced by many factors that don't directly affect Decision Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Decision Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Decision Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Decision Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.